NR3C1 and Borderline personality disorder: In a first global analysis, no differences were found between medicated BPD patients and healthy control group for nuclear expression of GR (x = 41.46 and x = 15.36, respectively), but significant differences appeared when the regression analysis was controlled for the effects of medication, particularly antipsychotics and mood stabilizers, showing significant differences in GR expression between patients and controls, with BPD patients showing lower GR expression (Figure 1).